BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15102599)

  • 21. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
    Walther W; Stein U
    Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.
    Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Carr IM; Stevenson AJ; Markham AF; Whitehouse A
    J Virol; 2000 Aug; 74(16):7331-7. PubMed ID: 10906186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors.
    Wieser C; Stumpf D; Grillhösl C; Lengenfelder D; Gay S; Fleckenstein B; Ensser A
    Gene Ther; 2005 Mar; 12(5):395-406. PubMed ID: 15647772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic analysis of herpesviruses and their potential use as vectors for gene therapy applications.
    Cotter MA; Robertson ES
    Curr Opin Mol Ther; 1999 Oct; 1(5):633-44. PubMed ID: 11249670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpesvirus saimiri-mediated delivery of the adenomatous polyposis coli tumour suppressor gene reduces proliferation of colorectal cancer cells.
    Macnab SA; Turrell SJ; Carr IM; Markham AF; Coletta PL; Whitehouse A
    Int J Oncol; 2011 Nov; 39(5):1173-81. PubMed ID: 21769429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
    Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
    J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy.
    Stevenson AJ; Frolova-Jones E; Hall KT; Kinsey SE; Markham AF; Whitehouse A; Meredith DM
    Cancer Gene Ther; 2000 Jul; 7(7):1077-85. PubMed ID: 10917211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpesvirus saimiri open reading frame 50 (Rta) protein reactivates the lytic replication cycle in a persistently infected A549 cell line.
    Goodwin DJ; Walters MS; Smith PG; Thurau M; Fickenscher H; Whitehouse A
    J Virol; 2001 Apr; 75(8):4008-13. PubMed ID: 11264393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector.
    Hiller C; Wittmann S; Slavin S; Fickenscher H
    Gene Ther; 2000 Apr; 7(8):664-74. PubMed ID: 10800089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells.
    Wade-Martins R; Saeki Y; Chiocca EA
    Mol Ther; 2003 May; 7(5 Pt 1):604-12. PubMed ID: 12718903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hybrid-vectors for delivery of autonomous replicons.
    Zhang W; Hagedorn C; Schulz E; Lipps HJ; Ehrhardt A
    Curr Gene Ther; 2014 Feb; 14(1):10-23. PubMed ID: 24365145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus type 1 amplicon vectors for the infectious delivery and expression of genomic DNA loci.
    Senior SL; Wade-Martins R
    Curr Opin Mol Ther; 2005 Aug; 7(4):337-45. PubMed ID: 16121699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene.
    Wade-Martins R; White RE; Kimura H; Cook PR; James MR
    Nat Biotechnol; 2000 Dec; 18(12):1311-4. PubMed ID: 11101814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral gene therapy.
    Mancheño-Corvo P; Martín-Duque P
    Clin Transl Oncol; 2006 Dec; 8(12):858-67. PubMed ID: 17169759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Herpesvirus saimiri as a potential human gene therapy vector.
    Stevenson AJ; Cooper M; Griffiths JC; Gibson PC; Whitehouse A; Jones EF; Markham AF; Kinsey SE; Meredith DM
    J Med Virol; 1999 Mar; 57(3):269-77. PubMed ID: 10022799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.